Melissa Geller, MD, MS graduated from Boston College (1994) (cum laude) in the field of Biology. She completed medical school at Chicago Medical School (1998). She went on to complete an Internship and Residency in Obstetrics and Gynecology at the University of Minnesota (2002) and a Fellowship in Gynecologic Oncology at the University of Minnesota (2005). In addition, Dr. Geller completed a Galloway Fellowship in the Department of Surgery, Gynecology Division at Memorial Sloan Kettering Cancer Center in New York in 2000. Dr. Geller completed a Master of Science degree in Clinical Research through the University of Minnesota through the School of Public Health in 2010.
Currently, Dr. Geller is a Professor in the Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology at the University of Minnesota. Dr. Geller specializes in the treatment and management of gynecologic malignancies and is committed to clinical and translational research. Dr. Geller has received independent funding for her projects and has published in peer-reviewed journals as well as presented her research at scientific meetings.
Dr. Geller is currently the University of Minnesota PI of multiple clinical trials run through the NRG, a national cooperative group, and the University of Minnesota Women's Cancer Center. She is the primary investigator on multiple clinical trials involving the use of natural killer (NK) cell immunotherapy for women with recurrent ovarian cancer. Her translational research is funded by the American Cancer Society (ACS) and involves the investigation of immunotherapies in an ovarian cancer mouse model. She currently holds a Department of Defense grant funding the creation of an interactive mobile phone application to educate women with ovarian cancer on the importance of genetic counseling for hereditary cancers.
